Faisal Mahmood: Excited to share PathChat, a multimodal generative AI copilot

Toni Choueiri shared a post by Faisal Mahmood, Associate Professor at Harvard University, on X:

“Very cool stuff from Faisal Mahmood group at Harvard Medical School, Brigham and Women’s Hospital pioneering work with AI and pathology, here in Nature.”

Quoting Faisal Mahmood‘s post:

“Excited to share our new Nature article building and evaluating PathChat, a multimodal generative AI copilot and chatbot for human pathology.
Open Access Link.
We leverage our previous success in building foundation models for computational pathology such as UNI / CONCH and combine it with the advancements of large vision language models and generative AI to enable PathChat to answer diverse pathology-related queries. We assessed PathChat using both multiple choice diagnostic questions and open-ended questions. Congratulations to Max Lu, Bowen Chen, Drew FK Williamson, Richard J. Chen and everyone else who contributed to this work. Also see blog post from Max Lu about this work, also teasing the development and preview of PathChat 2, a successor to PathChat 1 bringing new capabilities and substantially improved performance to the state-of-the-art.”

Source: Toni Choueiri/X and Faisal Mahmood/X

Toni Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is the Medical Director of International Strategic Initiatives at Dana-Farber and past President of the Medical Staff at DFCI (2016-2018).

He received the George Canellos Award for Excellence in Clinical Investigation and Patient Care from DFCI in 2013, the Eugene Schonfeld Award from the Kidney Cancer Association (KCA) in 2016, and is a 2021 Giants of Cancer Care inductee. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, KidneyCan Board, the National Cancer Institute (NCI) GU Steering Committee, and is past Chairman (2015-2018) of the Medical and Scientific Steering Committee of the KCA.

Dr. Choueiri is an elected member of the American Society of Clinical Investigation (ASCI). In addition, he is an Aresty Scholar from the Wharton School of Business at the University of Pennsylvania.